What have we learned from murine models of otitis media?

What have we learned from murine models of otitis media?

Otitis media (OM) is a common cause of childhood hearing loss. The large medical costs involved in treating this condition have meant that research to understand the pathology of this disease and identify new therapeutic interventions is important. There is evidence that susceptibility to OM has a s...

Полное описание

Библиографические подробности
Главные авторы:	Tyrer, H, Crompton, M, Bhutta, M
Формат:	Journal article
Язык:	English
Опубликовано:	2013

Схожие документы

edison - a novel model of otitis media
по: Crompton, M
Опубликовано: (2014)

Mouse models of otitis media: strengths and limitations.
по: Bhutta, M
Опубликовано: (2012)

What Have We Learned (or Expect to) From Analysis of Murine Genetic Models Related to Substance Use Disorders?
по: Gary Peltz, и др.
Опубликовано: (2022-01-01)

Genetics of chronic otitis media: a mouse to man approach
по: Bhutta, M
Опубликовано: (2012)

Decreased Expression of Aquaporins in Otitis Media: What About Chronic Otitis Media?
по: Shin Hye Kim, и др.
Опубликовано: (2019-08-01)

Chronic otitis media in mucopolysaccharidosis may not be due to Eustachian tube dysfunction.
по: Bhutta, M
Опубликовано: (2011)

What have we learned?
по: Peter Rodgers, и др.
Опубликовано: (2021-12-01)

What have we learned from the pandemic?
по: Iêda Maria Barbosa Aleluia
Опубликовано: (2021-03-01)

What have we learned from brucellosis in the mouse model?
по: Grilló María-Jesús, и др.
Опубликовано: (2012-04-01)

The pilocarpine model of epilepsy: what have we learned?
по: Fulvio A. Scorza, и др.
Опубликовано: (2009-09-01)

HIF-VEGF pathways are critical for chronic otitis media in Junbo and Jeff mouse mutants.
по: Cheeseman, M, и др.
Опубликовано: (2011)

Chernobyl and Fukushima nuclear accidents: What have we learned and what have we done?
по: Đurović Branka, и др.
Опубликовано: (2016-01-01)

GOAL: What Have We Learned?
по: Leek Timothy
Опубликовано: (2005-09-01)

PTH Assays: Understanding What We Have and Forecasting What We Will Have
по: Jose Gilberto H. Vieira
Опубликовано: (2012-01-01)

A modeling dialog with AI – what do we learn about what we have to learn?
по: Joolingen, Wouter van
Опубликовано: (2024)

Topical antibiotics for chronic suppurative otitis media
по: Brennan-Jones, C, и др.
Опубликовано: (2018)

What have we learned? : ten years on /
по: Ashkanasy, Neal M., 1945-, и др.
Опубликовано: (2011)

A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways.
по: Michael Crompton, и др.
Опубликовано: (2017-08-01)

Unraveling the genetics of otitis media: from mouse to human and back again.
по: Rye, MS, и др.
Опубликовано: (2011)

What we have learned from the Myriad trials.
по: Hendrix, S, и др.
Опубликовано: (2009)

What Have We Not Learned from the Convergence Debate?
по: Leone Leonida
Опубликовано: (2023-04-01)

What we have learned from the Rigopiano tragedy
по: Antonella Pescini, и др.
Опубликовано: (2019-12-01)

Cardiovascular Imaging: What Have We Learned From Animal Models?
по: Arnoldo eSantos, и др.
Опубликовано: (2015-10-01)

Hyperoxia and Lungs: What We Have Learned From Animal Models
по: Luciano Amarelle, и др.
Опубликовано: (2021-03-01)

The Gonadotropin-Inhibitory Hormone: What We Know and What We Still Have to Learn From Fish
по: María P. Di Yorio, и др.
Опубликовано: (2019-02-01)

Topical antibiotics with steroids for chronic suppurative otitis media
по: Brennan-Jones, C, и др.
Опубликовано: (2018)

Topical antibiotics for chronic suppurative otitis media
по: Brennan-Jones, CG, и др.
Опубликовано: (2019)

Orthopaedic infections: what have we learned?
по: Christopher Lee, MD, и др.
Опубликовано: (2023-05-01)

Development Economics: What Have We Learned?
по: Jagdish N. Bhagwati
Опубликовано: (1984-01-01)

Phage Therapy: What Have We Learned?
по: Andrzej Górski, и др.
Опубликовано: (2018-05-01)

COVID-19: what have we learned?
по: Yeh-Li Ho, и др.
Опубликовано: (2020-06-01)

Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
по: N I Volkova, и др.
Опубликовано: (2017-02-01)

The COVID-19 challenge. What have we learned?
по: Adrian Ceccato, и др.
Опубликовано: (2022-11-01)

COVID-19 pandemic. What have we learned?
по: Cristina Calvo, и др.
Опубликовано: (2021-11-01)

Nonpolyp‐associated otitis media in cats: The little we know
по: Mariana Bezerra Mascarenhas
Опубликовано: (2022-09-01)

What have we learned from the Young Lives study in Peru?
по: Cueto, S, и др.
Опубликовано: (2018)

A mutation in Nischarin causes otitis media via LIMK1 and NF-κB pathways
по: Crompton, M, и др.
Опубликовано: (2017)

What we have learned from COVID-19 pandemic?
по: Hsiu-Hsi Chen, и др.
Опубликовано: (2021-06-01)

Topical antiseptics for chronic suppurative otitis media
по: Head, K, и др.
Опубликовано: (2020)

Otitis media: recent advances in otitis media vaccine development and model systems
по: Ayesha Zahid, и др.
Опубликовано: (2024-01-01)